Key Laboratory of Agro-Products Processing, Ministry of Agriculture and Rural Affairs, Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing 100193, China; University of Liege-Gembloux Agro-Bio Tech, Laboratory of Biomass and Green Technologies, Passage des déportés 2, B-5030 Gembloux, Belgium.
Key Laboratory of Agro-Products Processing, Ministry of Agriculture and Rural Affairs, Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing 100193, China.
Carbohydr Polym. 2021 Aug 15;266:118099. doi: 10.1016/j.carbpol.2021.118099. Epub 2021 Apr 24.
Although chondroitin sulfate calcium complex (CSCa) was claimed to have the bioactivity for bone care in vitro, its anti-osteoporosis bioactivity was little reported in vivo. Here, the effects of CSCa on osteoporosis rats were investigated. Results showed that, compared with the osteoporosis rats, CSCa could improve the bone mineral density and microstructure of femur, and change the bone turnover markers level in serum. 16S rRNA sequencing and metabolomics analysis indicated CSCa intervention altered the composition of gut microbiota along with metabolite profiles in ovariectomized rat faeces. The correlation analysis showed some gut microbiota taxa were significantly correlated with osteoporosis phenotypes and the enriched metabolites. Taken together, dietary CSCa intervention has the potential to alleviate the osteoporosis and related symptoms probably involving gut microbiota or the metabolite profiles as demonstrated in rats. This study provides some scientific evidence for the potential effects of CSCa as the food supplement on the osteoporosis.
虽然硫酸软骨素钙复合物(CSCa)被声称具有体外骨骼护理的生物活性,但它在体内的抗骨质疏松生物活性却鲜有报道。本研究旨在探究 CSCa 对骨质疏松大鼠的作用。结果表明,与骨质疏松大鼠相比,CSCa 可改善股骨的骨矿物质密度和微结构,并改变血清中的骨转换标志物水平。16S rRNA 测序和代谢组学分析表明,CSCa 干预改变了肠道微生物群落的组成以及去卵巢大鼠粪便中的代谢物谱。相关性分析显示,一些肠道微生物群与骨质疏松表型和富集代谢物显著相关。综上所述,饮食中 CSCa 的干预有可能通过改善肠道微生物群或代谢物谱来缓解骨质疏松症及相关症状,这在大鼠中得到了证实。本研究为 CSCa 作为膳食补充剂对骨质疏松症的潜在作用提供了一些科学依据。